| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
European Molecular Biology Laboratory, Gene Expression Program, D-69117 Heidelberg, Germany
The ligand-binding domains of steroid receptors convey ligand-dependent regulation to certain proteins to which they are fused. Here we characterize fusion proteins between a site-specific recombinase, FLP, and steroid receptor ligand-binding domains. These proteins convert ligand binding into DNA recombination. Thus, ligand binding is directly coupled to an enzyme activity that is easily measured by DNA rearrangements or heritable genetic changes in marker gene expression, as opposed to the multiple events leading to transcription. Recombination by a FLP-estrogen receptor (FLP-EBD) fusion is activated by all tested estrogens, whether agonists or antagonists, indicating that all induce EBD release from the 90-kDa heat shock protein complex. Altering the distance between FLP and the EBD domain in the fusion proteins, by reducing the included length of the estrogen receptor D domain, affects ligand efficacy. A FLP-EBD with no D domain shows reduced inducibility by agonists and, unexpectedly, complete insensitivity to induction by all antagonists tested. A FLP-EBD including some D domain shows a ligand-inducible phenotype intermediate to those displayed by FLP-EBDs containing all or none of the D domain. Thus, we observed a tethered interference between FLP and the EBD domains that differs depending on the distance between the two domains, the conformations induced by agonists or antagonists, and which presents a previously undetectable distinction between estrogen agonists and antagonists in yeast.
This article has been cited by other articles:
![]() |
A. Koide, S. Abbatiello, L. Rothgery, and S. Koide Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor PNAS, January 24, 2002; (2002) 32665299. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Cheng, C.-R. Chang, P. Joy, S. Yablok, and M. R. Gartenberg Controlling gene expression in yeast by inducible site-specific recombination Nucleic Acids Res., December 15, 2000; 28(24): e108 - e108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rinaudo, S. Lamartina, G. Roscilli, G. Ciliberto, and C. Toniatti Conditional Site-Specific Integration into Human Chromosome 19 by Using a Ligand-Dependent Chimeric Adeno-Associated Virus/Rep Protein J. Virol., January 1, 2000; 74(1): 281 - 294. [Abstract] [Full Text] |
||||
![]() |
K Weigmann and S. Cohen Lineage-tracing cells born in different domains along the PD axis of the developing Drosophila leg Development, January 9, 1999; 126(17): 3823 - 3830. [Abstract] [PDF] |
||||
![]() |
G. G. J. M. Kuiper, J. G. Lemmen, B. Carlsson, J. C. Corton, S. H. Safe, P. T. van der Saag, B. van der Burg, and J.-A. Gustafsson Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor {beta} Endocrinology, October 1, 1998; 139(10): 4252 - 4263. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Logie, M. Nichols, K. Myles, J. W. Funder, and A. F. Stewart Positive and Negative Discrimination of Estrogen Receptor Agonists and Antagonists Using Site-Specific DNA Recombinase Fusion Proteins Mol. Endocrinol., August 1, 1998; 12(8): 1120 - 1132. [Abstract] [Full Text] |
||||
![]() |
A. Koide, S. Abbatiello, L. Rothgery, and S. Koide Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor PNAS, February 5, 2002; 99(3): 1253 - 1258. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |